Literature DB >> 15351786

Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif.

Peter Geserick1, Frank Kaiser, Uwe Klemm, Stefan H E Kaufmann, Jens Zerrahn.   

Abstract

The regulatory networks governing development and differentiation of hematopoietic cells are incompletely understood. Members of the Schlafen (Slfn) protein family have been implicated in the regulation of cell growth and T cell development. We have identified and chromosomally mapped four new members, slfn5, slfn8, slfn9 and slfn10, which belong to a distinct subgroup within this gene family. The characteristic feature of these proteins is the presence of sequence motifs identifying them as distinct members of the superfamily I of DNA/RNA helicases. A significant role of these newly identified members in hematopoietic cell differentiation is suggested based on their differential regulation (i) in developing and activated T cells, (ii) in LPS or IFNgamma activated macrophages, (iii) upon IL6 or LIF driven terminal differentiation of myeloblastic M1 cells into macrophage-like cells, and (iv) in splenocytes of mice infected with Listeria monocytogenes. In contrast to wild-type cells, IRF-1 and IFNalpha/betaR deficient macrophages, although undergoing growth arrest, fail to upregulate slfn gene expression upon IFNgamma or LPS stimulation, respectively. Therefore, an essential participation in IFNgamma or LPS induced growth arrest appears unlikely. Likewise, ectopic expression of the newly identified slfn family members in fibroblasts did not reveal a general impact on growth control. In contrast, transgenic T-cell specific expression of a representative member of this new subfamily, slfn8, resulted in profoundly impaired T cell development and peripheral T cells showed a reduced proliferative potential. Thus, functional participation of slfn8 in the regulatory networks governing T cell development and growth appears to be cell type specific.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351786     DOI: 10.1093/intimm/dxh155

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  69 in total

1.  The paternal gene of the DDK syndrome maps to the Schlafen gene cluster on mouse chromosome 11.

Authors:  Timothy A Bell; Elena de la Casa-Esperón; Heather E Doherty; Folami Ideraabdullah; Kuikwon Kim; Yunfei Wang; Leslie A Lange; Kirk Wilhemsen; Ethan M Lange; Carmen Sapienza; Fernando Pardo-Manuel de Villena
Journal:  Genetics       Date:  2005-09-19       Impact factor: 4.562

2.  Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer.

Authors:  Edoardo Isnaldi; Domenico Ferraioli; Lorenzo Ferrando; Alberto Ballestrero; Gabriele Zoppoli; Sylvain Brohée; Fabio Ferrando; Piero Fregatti; Davide Bedognetti
Journal:  Breast Cancer Res Treat       Date:  2019-06-20       Impact factor: 4.872

3.  Schlafen 12 expression modulates prostate cancer cell differentiation.

Authors:  Pavlo L Kovalenko; Marc D Basson
Journal:  J Surg Res       Date:  2014-03-27       Impact factor: 2.192

4.  Schlafen 14 (SLFN14) is a novel antiviral factor involved in the control of viral replication.

Authors:  Rak-Kyun Seong; Seong-Wook Seo; Ji-Ae Kim; Sarah J Fletcher; Neil V Morgan; Mukesh Kumar; Young-Ki Choi; Ok Sarah Shin
Journal:  Immunobiology       Date:  2017-07-11       Impact factor: 3.144

5.  Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.

Authors:  Myeong Sup Lee; Byungil Kim; Sun-Min Lee; Woo-Cheul Cho; Wook-Bin Lee; Ji-Seon Kang; Un Yung Choi; Jaemyun Lyu; Young-Joon Kim
Journal:  Mol Cells       Date:  2013-05-10       Impact factor: 5.034

6.  The P-loop region of Schlafen 3 acts within the cytosol to induce differentiation of human Caco-2 intestinal epithelial cells.

Authors:  Lakshmishankar Chaturvedi; Kelian Sun; Mary F Walsh; Leslie A Kuhn; Marc D Basson
Journal:  Biochim Biophys Acta       Date:  2014-09-28

Review 7.  Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.

Authors:  Junko Murai; Anish Thomas; Markku Miettinen; Yves Pommier
Journal:  Pharmacol Ther       Date:  2019-05-23       Impact factor: 12.310

8.  Schlafen 3 changes during rat intestinal maturation.

Authors:  Mary F Walsh; Rebecca Hermann; Kelian Sun; Marc D Basson
Journal:  Am J Surg       Date:  2012-08-17       Impact factor: 2.565

9.  An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.

Authors:  Michael Berger; Philippe Krebs; Karine Crozat; Xiaohong Li; Ben A Croker; Owen M Siggs; Daniel Popkin; Xin Du; Brian R Lawson; Argyrios N Theofilopoulos; Yu Xia; Kevin Khovananth; Eva Marie Moresco; Takashi Satoh; Osamu Takeuchi; Shizuo Akira; Bruce Beutler
Journal:  Nat Immunol       Date:  2010-02-28       Impact factor: 25.606

10.  Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.

Authors:  Caroline Gubser; Rory Goodbody; Andrea Ecker; Gareth Brady; Luke A J O'Neill; Nathalie Jacobs; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2007-06       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.